Cargando…
Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone
BACKGROUND: There are limited long-term randomized controlled trials of growth hormone (GH) supplementation to adult height and few published reports of the health-related quality of life (HRQOL) following treatment. The present follow-up study of young adults from a long-term controlled trial of GH...
Autores principales: | Taback, Shayne P, Van Vliet, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125334/ https://www.ncbi.nlm.nih.gov/pubmed/21619701 http://dx.doi.org/10.1186/1471-2431-11-49 |
Ejemplares similares
-
Recombinant human growth hormone in the treatment of Turner syndrome
por: Spiliotis, Bessie E
Publicado: (2008) -
Growth Hormone Supplementation and Psychosocial Functioning to Adult Height in Turner Syndrome: A Questionnaire Study of Participants in the Canadian Randomized Trial
por: Rovet, Joanne F., et al.
Publicado: (2019) -
Hypertrophic scars in a patient with Turner's syndrome treated with recombinant growth hormone
por: Kędzia, Andrzej, et al.
Publicado: (2014) -
Metabolic consequences of recombinant human growth hormone therapy in patients with Turner syndrome
por: Gnacińska, Maria, et al.
Publicado: (2022) -
Health-Related Quality of Life in Turner Syndrome and the Influence of Growth Hormone Therapy: A 20-Year Follow-Up
por: Krantz, Emily, et al.
Publicado: (2019)